Device Trial Radar · NCT02840422
Assessment of Patients Quality of Life Treated With Three ARTHRUM H 2% Joint Injections
Last checked: Nov 20, 2026Latest source record: Jan 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
138
Actual
Start
Feb 3, 2016
Primary completion
Dec 8, 2016
Study completion Jul 28, 2017
Sponsor
- Lead sponsor
- LCA PharmaceuticalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 21, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The reduction of functional limits and disablilities induced by knee osteoarthritis as well as improvement of patients quality of life is a public health need registered amongst the priorities established by the French law of August 9th 2004 relative to Public Health policy. However, the response to this need is not limited to treatment with health products. This clinical trial in real life on ARTHRUM H 2% device aims to analyse patients quality of life treated by intraarticular injections, eventually for several years, by difference of usual clinical trials. This open, prospective, multicentric study aims to analyse, in patient care, the impact of three intraarticular injections of ARTHRUM H 2% on quality of life over a period of 6 months (D180) in the symptomatic treatment of knee osteoarthritis.
Conditions
- Knee Osteoarthritis
Interventions
ARTHRUM H 2%Device
ARTHRUM H 2%
Primary outcomes
What the sponsor says the trial is designed to measure.
- To measure the physical component summary (PCS) improvement, on patient quality of life suffering from knee osteoarthritis after treatment by three intraarticular injections of ARTHRUM H 2% from D0 (inclusion) to D180 (end of trial)Time frame: 6 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.